Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
Nature Communications(1)
Proceedings of the National Academy of Sciences of the United States of America(1)
Scientific Reports(1)
Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infections
ArticleAbstract: The increased prevalence of drug-resistant human pathogenic fungal diseases poses a major threat toPalabras claves:acetohydroxyacid synthase, Antifungal drug, Candida Albicans, Crystal structure, HerbicideAutores:Agnew-Francis K., Chua S.M.H., Fraser J.A., Guddat L.W., Lee Y.T., Lonhienne T., Low Y.S., Mario D. Garcia, Mario Daniel García, Nouwens A., Wang J.G., Williams C.M.Fuentes:googlescopusTriazolopyrimidine herbicides are potent inhibitors of Aspergillus fumigatus acetohydroxyacid synthase and potential antifungal drug leads
ArticleAbstract: Aspergillus fumigatus is a fungal pathogen whose effects can be debilitating and potentially fatal iPalabras claves:Autores:Fraser J.A., Guddat L.W., Lonhienne T., Low Y.S., Mario D. Garcia, Mario Daniel García, Schenk G.Fuentes:googlescopusStructural basis of resistance to herbicides that target acetohydroxyacid synthase
ArticleAbstract: Acetohydroxyacid synthase (AHAS) is the target for more than 50 commercial herbicides; first appliedPalabras claves:Autores:Cheng Y., Guddat L.W., Hu S.H., Lonhienne T., Low Y.S., Mario D. Garcia, Mario Daniel García, Schenk G., Williams C.M.Fuentes:googlescopusSusceptibility analysis of mutations that confer resistance to inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp)
OtherAbstract: Enormous efforts have been made worldwide to generate therapeutic options to prevent the transmissibPalabras claves:Autores:Mario D. GarciaFuentes:google